. 16S rRNA PCR served as a reference. pET15b DNA was used to control for the size of the amplified fragments. (B) SDS-PAGE of U and H pellet fractions (10 g). CBB staining. Bands 1-6 were excised from the gel and subjected to MS analysis and microsequencing (see also Table S2 ). (C) Mass spectra of the purified recombinant U and H proteins. The predicted mass of the 6xHis-tagged protein (U or H) is 21788.37 Da. A characteristic PK-resistant fragment has a size similar to that of isolated NTD (γBN). Middle and right panels: pulse proteolysis of ribosome-bound and puromycin-released gamma-B crystallin U and H, respectively. , which lacks the ribosomeassociated chaperone Trigger Factor. Freshly transformed E. coli cells harboring either U or H gamma-B crystallin variants were grown in flasks with 50 mL of liquid Luria Bertani (LB) medium containing 100 µg/mL ampicillin at 37°C with shaking at 230 rpm until the cultures reached an OD 600 of 0.8. Protein expression was induced by addition of 1 mM IPTG (isopropyl-β-d-thiogalactopyranoside) and incubation was continued for an additional 1.5 h at 37°C with shaking. Cells were harvested by centrifugation (3200×g, 15 min). Cell pellets were re-suspended in 1 mL of 50 mM Tris-HCl buffer, pH 8.0, containing 500 mM NaCl and 1 tablet of EDTA-free protease inhibitor cocktail (Roche), and sonicated (20 s, 3 times) using an ultrasonic processor (Fisher Scientific). Lysates were pelleted at 17,000×g for 30 min, using a TLA-55 fixed-angle rotor (Beckman Coulter) to separate insoluble/aggregated proteins (pellet) from soluble protein (supernatant). The supernatant was transferred into a clean tube. The pellet was re-suspended in an equal (to that of supernatant) volume of 50 mM Tris-HCl buffer, pH 8.0, containing 500 mM NaCl and EDTA-free protease inhibitor cocktail (Roche).
SUPPLEMENTAL TABLES

Quantitative RT-PCR
For analysis of relative mRNA expression levels, total RNA was isolated from E. coli BL21 (DE3) Δtig::Kan cells expressing U and H variants using Trizol Reagent (Life Technologies). Total RNA (2 g) was subjected to DNAse treatment (Promega) and 1 g of DNAse-treated RNA was used for cDNA amplification with the Invitrogen Superscript III RT kit (Life Technologies). PCR reactions were carried out for 21 cycles (to avoid saturation) using the following gamma-B crystallin U/H variant-specific primers: U forward: 5'-AAAAACCATGGGGAAGATCACTTTTTAC-3' U reverse: 5'-GAAAGTGCCGGTGTGTTGCGG-3 H forward: 5'-AAAAACCATGGGAAAAATCACTTTCTATG-3' H reverse: 5'-CCGAAAAGTACCGGTATGTTGTGG-3', Both the U and H primer pairs generated products 264 bp length. PCR without RT, using DNAse-treated RNA as the template was used to control for plasmid DNA contamination. Amplified fragments of 16S rRNA were used as reference standards (16S rRNA forward primer: 5'-GCTACAATGGCGCATACAAA-3'; 16S rRNA reverse primer: 5'-TTCATGGAGTCGAGTTGCAG-3'; 101 bp PCR product).
Analysis of recombinant protein expression
Protein concentrations in samples were determined using a Coomassie (Bradford) Protein Assay Kit (Thermo Scientific) with bovine serum albumin (BSA) as a reference standard and equal total protein amounts were analyzed for each sample. For Western blotting, 2 µg total protein (soluble and/or insoluble fractions) was separated under reducing conditions using TrisTricine SDS-PAGE using a 4% stacking and a 16.5% separation gel (49.5% T, 3% C). Proteins were transferred to a 0.45 µm pore size PVDF membrane (EMD Millipore) using a wet Mini Trans-Blot blotting system (Bio-Rad Laboratories) at 110V for 1.5 h. The membrane was blocked (7.5% non-fat dry milk, TBS, 0.1% Tween) for 1 h at room temperature, washed and probed with either anti-gamma-B crystallin antibody (1:1000 dilution, P-18, Santa Cruz Biotechnology) ( Figure 1C ) or with mouse monoclonal anti-poly-histidine antibody (1:3000, H1029, Sigma) ( Figure 1E ). Membranes were then incubated with secondary donkey anti-goat IgG-HRP (1:2000, Santa Cruz Biotechnology) or goat anti-mouse IgGH&L(HRP) (1:4000, ab6789, Abcam) antibodies. Signals were detected using ECL Plus reagent (GE Healthcare) and a Typhoon 9410 imaging scanner (GE Healthcare). Band intensities were quantified using either Image Quant (v. 2005) or ImageJ software. For ELISA, 2 µg of total cellular protein in 200 mM sodium carbonate/bicarbonate buffer, pH 9.5 was coated on 96 well plates and incubated overnight, at 4°C. Protein was blocked using 300 µL blocking buffer containing 7.5% non fat dry milk (Promega) in 0.1% Tris-Buffered Saline (TBS) per well and incubated for 1 hr at room temperature. After 1 hr, blocking buffer was removed and 200 µL of polyclonal anti-gamma-B crystallin antibody (P-18, Santa Cruz Biotechnology, 1:1000) diluted in 7.5% non fat dry milk, 0.1% tween TBS was added to each well and incubation was continued on shaking platform for 1 hr at room temperature. Wells were washed with 300 µl wash buffer (0.1% tween TBS) for 5 min (×3). After washing, secondary donkey anti-goat IgG-HRP antibody (1:2000) (Santa Cruz Biotechnology) diluted in 7.5% non fat dry milk, 0.1% tween TBS was added and incubation was continued for 1 hr on shaking platform followed by washing with 300 µL of wash buffer (0.1% tween TBS) for (5 min x 3 times). For detection, 100 µL of TMB One Solution (Promega) was added to each well and the samples were incubated for 10 min with shaking in the dark at room temperature. Reactions were stopped by adding 100 µL of 1N hydrochloric acid (HCl) to each well. Protein was detected by recording the absorbance at 450 nm on Victor3™ Plate reader (PerkinElmer). Percentages of the soluble and pellet fractions were calculated as a fraction of the total protein.
Recombinant protein purification
Gamma-B crystallin protein variants expressed as described above were isolated using immobilized metal-affinity chromatography (IMAC) on Ni-Nitrilotriacetic Acid Agarose (Ni-NTA) (Qiagen) followed by size-exclusion chromatography (SEC) on a Superdex 75 gel-filtration column (1.6 cm×60 cm) (GE Healthcare) using an ÄKTA purifier liquid chromatography system (GE Healthcare). Gamma-B crystallin fractions were collected and concentrated using an Amicon Ultra-4 centrifugal device (EMD Millipore). Aliquots were flash frozen in liquid nitrogen and stored at -80°C. The purified protein samples were subjected to MS analysis and microsequencing at either the Cleveland Clinic proteomics core facility or the Harvard Mass Spectrometry facility.
Gamma-B crystallin purification from bovine eye lenses
Gamma-B crystallin from bovine eye lenses (native protein, N) was purified generally as described (Slingsby and Miller, 1983) with the following modifications. Frozen lenses collected from young cows (less than 30 months old) were purchased from Animal Technologies (Tyler, TX, USA). Lenses were thawed, decapsulated and homogenized in 50 mM Tris-HCl buffer, pH 7.2, containing 1 tablet of EDTA-free protease inhibitor cocktail (Roche). After the homogenate was centrifuged at 27,000×g for 30 min, the pellet was discarded and the supernatant was filtered and used for further purification. Gamma crystallins were separated from other proteins (including alpha-and beta-crystallins) by SEC using a Superdex 75 gelfiltration column (1.6 cm×60 cm, GE Healthcare) on an ÄKTA purifier liquid chromatography system (50 mM Tris-HCl buffer, pH 7.2, flow-rate 0.75 mL/min). Fractions containing gamma crystallins were collected and dialyzed against 20 mM Tris-acetate, pH 6.0 (buffer A). Proteins were further separated by cation exchange chromatography on a Mono S 5/50 Column (GE Healthcare). The column was equilibrated and washed with buffer A and a gradient and stepwise elution of buffer B (20 mM Tris-Acetate, 0.4 M sodium acetate, pH 6.0) was used. Elution was done by running a 5-10% buffer B gradient for 2.5 min, 10% isocratic buffer B for 10 min, followed by a 10-40% buffer B gradient for 15 min (flow rate 0.5 mL/min). To identify fractions containing gamma-B crystallin, proteins from each isolated peak were run on Tris-tricine SDS-PAGE gels, Coomassie stained, and submitted for MS analysis and microsequencing (Table S3) .
Proteolysis of purified gamma-B crystallin
For proteinase K (PK) proteolysis under native/non-denaturing conditions, 190 pmol (4 µg) of purified gamma-B crystallin (U, H and/or N) in 50 mM Tris-HCl pH 8.0, 200 mM NaCl were treated with 38 pmol (1.1 µg) PK at 37°C. Reactions were stopped by PMSF addition (10 mM final concentration) and samples were immediately flash frozen in liquid nitrogen, thawed, mixed with 2X Tris-tricine loading buffer and resolved on Tris-tricine SDS-PAGE gels (Schägger and von Jagow, 1987) . For proteolysis under denaturing conditions, gamma-B crystallin (U, H and/or N) in 50 mM Tris-HCl, pH 8.0, 200 mM NaCl, 3M GuHCl was first denatured at 37°C for 24 h and then subjected to PK treatment as described above.
Mass spectrometry
Identification of gamma-B crystallin protein products was carried out by LC-MS/MS analysis at the Cleveland Clinic Mass Spectrometry Laboratory for Protein Sequencing (Cleveland, OH) and the Harvard Mass Spectrometry facility (Cambridge, MA). Finnigan LTQ-Obitrap Elite hybrid mass spectrometer systems were used. Purified proteins or gel-separated protein products were subjected to MS analysis. For in-gel protein digestion, bands were excised, washed with water, and dehydrated in acetonitrile. The bands were then reduced with DTT and alkylated with iodoacetamide prior to in-gel digestion. Bands were digested in-gel by adding either 5 μL 10 ng/μL trypsin or 10 ng/μL chymotypsin in 50 mM ammonium bicarbonate and incubating overnight at room temperature to achieve complete digestion. Peptides were extracted with a 50% acetonitrile, 5% formic acid solution, evaporated to <10 μL using a Speedvac and resuspended in 1% acetic acid to a final volume of 30 μL for LC-MS/MS analysis. mRNA for in vitro translation mRNAs coding for full-length U and H protein variants, or the N-terminal fragment (amino acids 1-89) of U and H, were prepared by T7 transcription using pET15b-based constructs containing the corresponding sequences. Neither construct contained the C-terminal 6xHis tag or a stop codon. The T7 forward primer (5'-GATCCCGCGAAATTAATACGACTC-3') was used with the following reverse primers: U (full-length): 5'-ATAAAAATCCATCACCCGTCTTAAAGAACC-3'; U (1-89): 5'-GAAAGTGCCGGTGTGTTGCG-3'; H (full-length) 5'-GTAGAAGTCCATAACGCGCCGTA-3'; and H (1-89): 5'-AAAAGTACCGGTATGTTGTGGGATTAAG-3'. For FRET experiments, the threonine codon at position 88 (counting from the initiator Met) of full-lengths U or H mRNA was replaced by an amber stop codon UAG. The position 88 was chosen because it is located (i) close to the end of the NTD (position 80), which should allow for monitoring the NTD folding as soon its synthesis is completed, and (ii) at a distance that would allow efficient FRET, and because the linker can be replaced without a change in protein stability (Mayr et al., 1994) .
Fluorescence-labeled tRNAs
To obtain BOP-Met-tRNA fMet , [ 3 H]Met-tRNA fMet (15 µM) was labeled with Bodipy576/589-NHS (5 mM) (MolecularProbes) in 100 mM sodium acetate pH 5.0, 80% DMSO for 18 h at 4°C. Unreacted fluorophore was removed by extraction with 50:50 phenol:chloroform mixture followed by ethanol precipitation. BOP-Met-tRNA fMet was purified by HPLC on a LiChrospher WP300 RP-18 column using a gradient of 5 to 40% ethanol in 20 mM ammonium acetate, 10 mM MgCl 2 , 400 mM NaCl pH 4.5. The gene coding for E. coli tRNA Cys under a T7 promotor was generated by primer overlap PCR and was ligated into the SmaI site of pUC19. Genes coding for amber, opal and ochre suppressor tRNA Cys variants were constructed by site-directed mutagenesis of the anticodon. tRNA Cys variants were generated by in vitro transcription and purified on a HiTrapQ column (GE healthcare) using a linear gradient of 0 to 1.1 M NaCl in 50 mM sodium acetate pH 5.0 and 10 mM MgCl 2 . Aminoacylation was carried out in 100 mM HEPES pH 7.5, 15 mM KCl, 7 mM MgCl 2, 5 mM DTT with 2 mM ATP, 150 µM L-cysteine, 35 A 260 units/mL of tRNA Cys variant, and 6 µM CysRS-His 6 for 45 min at 37°C. The yield of aminoacylation was 50% for all variants. Opal suppressor Cys-tRNA
Cys from E. coli was reported to be active in translation in rabbit reticulocyte and wheat germ extracts (Gubbens et al., 2010) . In contrast, in the E. coli system, only wt tRNA Cys and the amber suppressor tRNA Cys CUA were active. To improve the decoding properties of tRNA Cys CUA, we introduced a further replacement into the anticodon loop, U32 to C, which restored the rate of decoding to the level of wt tRNA Cys (Olejniczak and Uhlenbeck, 2006) . Cys-tRNA Cys CUA U32C (30 µM) was labeled with BodipyFL-C 1 -IA (Molecular Probes) (1 mM) in 50 mM Hepes pH 7.5, 50% DMF for 45 min at 25°C. Unreacted fluorophore was removed by extraction with 50:50 phenol:chloroform mixture followed by ethanol precipitation. BOF-Cys-tRNA Cys CUA U32C was separated from deacylated and unlabeled tRNA by HPLC on a LiChrospher WP300 RP-18 column using a gradient of 5 to 40% ethanol in 20 mM ammonium acetate, 10 mM MgCl 2 , 400 mM NaCl.
In-vitro translation
Translation in the fully reconstituted single-turnover in vitro translation system was carried out as described (Doerfel et al., 2013; Mittelstaet et al., 2013) . 70S initiation complexes (IC) were prepared by incubating 70S ribosomes (purified from E. coli MRE 600 strain (Rodnina, and Wintermeyer, 1995) (Milon et al., 2007) ; typically, all added fluorescence-labeled [ 3 H]Met-tRNA fMet was found in the complex with the ribosome. IC stock (0.125 µM) was diluted to HiFi translation buffer (50 mM Tris-HCl, pH 7.5, 70 mM NH 4 Cl, 30 mM KCl, 3.5 mM MgCl 2 , 0.5 mM spermidine, 8 mM putrescine, 2 mM DTT). Factor mix (FM) was formed by incubating elongation factor (EF) EF-Tu-GDP (250 µM), GTP (2 mM), phosphoenolpyruvate (6 mM), pyruvate kinase (2%), and EF-G (7.5 M) at 37°C for 15 min, followed by addition of purified total E. coli aa-tRNA (100 µM) aminoacylated with the mixture of amino acids containing [
14 C]Phe and additional incubation for 2 min at 37°C. The concentrations of the components in the in vitro system were optimized to achieve the speed and fidelity similar to that in vivo (Wohlgemuth et al., 2010; Rudorf et al., 2014) . In vitro translation was initiated by rapid mixing of IC (0.015 µM) with FM (40 µM ternary complex) at 37°C. At indicated time points after the start of translation, aliquots (25 µl) were withdrawn and the reaction was stopped by adding 5 µl of 2 M NaOH and digested for 30 min at 37°C. The efficiency of translation was tested by precipitating the peptides by cold trichloroacetic acid (5%) and measuring [ 3 H]Met and [ 14 C]Phe incorporation into proteins; typically, 70-80% of the IC carried peptides of expected length. 2 M Hepes acid (5.5 µL) and 2X loading buffer (50 mM Tris-HCl, pH 6.8, 12% (w/v) glycerol, 2% β-mercaptoethanol, 4% SDS) was added to each sample and the translation products were separated by Tris-tricine SDS-PAGE using 4% stacking, 10 % spacer and 16.5 % separation gels (49.5% T, 3% C). The gel was washed with water and scanned on a FLA-9000 fluorescence imager (Fujifilm Lifescience). Fluorescence was excited at 473 nm and monitored after passing a LPB (510LP) filter. Because the mRNAs used for translation did not have a stop codon, translation was limited to a single round per ribosome and the nascent peptides did not dissociate from the ribosome, unless released by puromycin treatment. For FRET experiments, translation was carried out with an IC containing BOP-Met-tRNA fMet and an mRNA variant containing a UAG stop codon at position 88. The stop codon was decoded by an amber suppressor tRNA Cys CUA U32C (Gubbens et al., 2010) aminoacylated with Cys and thiol-modified by BOF. The fluorophores BOF or BOP were exited at 470 nm and 540 nm, respectively. The emission of BOF was monitored after passing a 500 nm cut-off filter; the emission of BOP after a 570 nm cut-off filter. As the acceptor-only control, unlabeled Cys-tRNA Cys CUA U32C was used. Cys-tRNA Cys CUA U32C was separated from deacylated tRNA by purifying the ternary complex EF-Tu•GTP•Cys-tRNA Cys CUA U32C on a Superdex 75 10/300 size exclusion column.
Protein expression and purification for NMR spectroscopy
Aliquots of Invitrogen OneShot BL21(DE3) E. coli cells (Life Technologies) or SHuffle T7 E. coli cells (NEB) were freshly transformed with the pET15b plasmid (U or H) and incubated overnight in 50 mL LB medium containing 100 mg/L ampicillin (37°C, 220 rpm shaking). Pre-cultures were pelleted (15 min, 5000×g, 4°C) and resuspended in a small volume of the final expression medium, which was then used to inoculate main cultures to a starting OD 600 of 0.2 -0.3 for BL21(DE3) and 0.5 for SHuffle T7 cells. All expression media contained 100 mg/L ampicillin. A rich medium for uniform 15 N-labeling, Celltone Complete (98% 15 N, Cambridge Isotope Labs) was used (incubation conditions: 250 mL culture volume in 1 L baffled flasks, 37°C, 160-180 rpm). 
